Net Good IndexSubmit a correction

Benefit Ledger · provisional · Biology

HARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design

Targeting RNA with small molecules is increasingly viewed as a pivotal strategy for future therapeutics. A major limitation in studying RNA-small molecule (RNA-SM) interactions is the lack of available experimental structures. HARIBOSS established a milestone as a curated database of RNA-SM complexes derived from the Protein Data Bank. Building on its community engagement, we present HARIBOSS++, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs. Major updates include an extension of the pocketome to encompass binding sites where small molecul

Tier 1 UsefulMethodology 0.1
Submit a correction

Current score

+0.00

1 base · Useful (tier 1 of 5, 1 pts)
× 0.1000 attribution · Minor documented assistance
× 0.1000 evidence · Firsthand or social claim
× 0.2000 realization · Proposed
× 0.5000 durability · Medium-term
Event-level product before credit split: 0.00

Auto-published from news ingest as a provisional placeholder. Score is conservative until a named release is identified and the record is rescored.

What happened

Targeting RNA with small molecules is increasingly viewed as a pivotal strategy for future therapeutics. A major limitation in studying RNA-small molecule (RNA-SM) interactions is the lack of available experimental structures. HARIBOSS established a milestone as a curated database of RNA-SM complexes derived from the Protein Data Bank. Building on its community engagement, we present HARIBOSS++, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs. Major updates include an extension of the pocketome to encompass binding sites where small molecules interact not only with RNA but also with other biomolecules, enhanced analysis of RNA molecules by family, detailed 3D structural characterization, improved analysis of ligands chemical space, addition of experimental binding affinity as well as molecular dynamics data, when available. HARIBOSS++ opens new avenues for biologists, bioinformaticians, and machine learning researchers to investigate RNA-SM interactions on a new scale. HARIBOSS++ can be explored using a web interface freely available at https://hariboss.pasteur.cloud.

Model attribution

Unspecified AI system
Version unspecified
+0.00

Unspecified

Unspecified system mentioned or implied by a news item. Remap to a named release when identified.

News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.

Attribution 0.1000 · Credit share 100% · Unknown

Claims

  • HARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design

    outcome · supported

Sources

primary sources

Revision history

  • 14 Sep 2026 · 0.00 0.00

    Auto-published from news ingest.